SGLT2i treatment at the beginning of real time exposure in a HFrEF population

被引：0
|
作者：
Vintila, V. [1 ]
Ciocanel, A. [2 ]
Stamate, E. [2 ]
Vintila, A. M. [3 ]
Vinereanu, D. [1 ]
机构：
[1] Univ Med & Pharm Carol Davila, Univ & Emergency Hosp Bucharest, Cardiol Dept, Bucharest, Romania
[2] Univ Emergency Hosp Bucharest, Cardiol Dept, Bucharest, Romania
[3] Univ Med & Pharm Carol Davila, Internal Med Dept, Coltea Clin Hosp, Bucharest, Romania
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：251 / 251
页数：1
相关论文
共 50 条
  • [21] Real-life introduction of SGLT2i during an hospitalization for heart failure
    Brisse, A.
    Huttin, O.
    Zannad, N.
    Girerd, N. Nicolas
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 304 - 304
  • [22] SGLT2i in CKD with high albuminuria: an observational real-world study
    Svensson, Maria K.
    Bodegard, Johan
    Thuresson, Marcus
    Ambery, Philip
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [23] SGLT2i in heart failure with reduced ejection fraction: benefits in real life?
    Sanchez Gonzalez, V. Virtudes
    Flano-Lombardo, R.
    Esteve-Ruiz, I.
    Cortez, G.
    Aranda-Dios, A.
    Duran-Torralba, C.
    Rangel-Sousa, D.
    Sobrino-Marquez, J. M.
    Grande-Trillo, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 72 - 73
  • [24] USE OF SGLT2-i IN ELDERLY PATIENTS WITH HFrEF- REAL WORD DATA
    Verga, F.
    Orso, F.
    Salucci, C.
    Corti, G.
    Graziani, M.
    Alfano, F.
    Poletti, E.
    Cagnoni, C.
    Ungar, A.
    Baldasseroni, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26 : ii87 - ii88
  • [25] Dramatic disease regression in a case of HFrEF with end-stage renal failure treated with sacubitril/valsartan and SGLT2i
    Mapelli, Massimo
    Mantegazza, Valentina
    Ferrari, Cristina
    Cimino, Roberto
    Maragna, Riccardo
    Pontone, Gianluca
    Pepi, Mauro
    Agostoni, Piergiuseppe
    ESC HEART FAILURE, 2023, 10 (03): : 2099 - 2106
  • [26] Sacubitril/Valsartan and SGLT2i: a safe combination?
    Goena, C.
    Natividad, R.
    Rilo, I.
    Gomez, C.
    Perez De Nanclares, M.
    Lozano, A.
    Quintas, L.
    Zugazabeitia, G.
    Solla, I.
    Escolar, V.
    Rodriguez, I.
    Gil, P.
    Laskibar, A.
    Urreta, I.
    Romero, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 141 - 141
  • [27] SGLT2I AS RENOPROTECTION TOOL IN CHILDREN WITH CKD
    Ivanov, Dmytro
    Ivanova, Mariia
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3325 - 3325
  • [28] Will the SGLT2i Responders Please Stand Up?
    Banner, Kane
    Silverman, Daniel N.
    CIRCULATION-HEART FAILURE, 2023, 16 (11)
  • [29] Hypertension approaches and recent SGLT2i studies
    Bloomgarden, Zachary
    JOURNAL OF DIABETES, 2024, 16 (11)
  • [30] Mineral and Electrolyte Disorders With SGLT2i Therapy
    Cianciolo, Giuseppe
    De Pascalis, Antonio
    Capelli, Irene
    Gasperoni, Lorenzo
    Di Lullo, Luca
    Bellasi, Antonio
    La Manna, Gaetano
    JBMR PLUS, 2019, 3 (11)
12345